Alex Denner's firm takes over Amarin, ousts non-Sarissa board members

Activist investor Alex Denner has now solidified his control over Irish drugmaker Amarin.

In the wake of last week’s shareholder election that saw Denner’s VC Sarissa Capital Management install seven directors on Amarin’s board, the company announced Monday afternoon that the seven non-Sarissa board members are exiting from their positions “to avoid further proxy contests.”